Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics
摘要:
We have introduced solubilizing functionality to a 3,6-disubstituted pyrazolo[1,5-a]pyrimidine series of KDR kinase inhibitors to improve the physical properties of these compounds. The addition of a basic side-chain to the 6-aryl ring, introduction of 3-pyridyl groups, and most significantly, incorporation of a 4-pyridinonyl substituent at the 6-position of the core are modifications that maintain and often enhance the intrinsic potency of this class of inhibitors. Moreover, the improvements in physical properties result in marked increases in cellular activity and more favorable pharmacokinetics in rats. The synthesis and SAR of these compounds are described.(C) 2002 Elsevier Science Ltd. All rights reserved.
between compounds with pyrazolo[1,5-a]pyrimidine structure (series 4-6) and pyrazolo[5,1-c][1,2,4]triazine core (series 9) as ligands at GABAA-receptor subtype, was evaluated. Moreover, for pyrazolotriazine derivatives having binding recognition, the interaction on recombinant rat α(1-3,5) GABAA receptor subtypes, was performed. Among these latter, emerge compounds 9c, 9k, 9l, 9m and 9n as α1-selective
Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABAA-R ligands
作者:Gabriella Guerrini、Giovanna Ciciani、Simona Daniele、Lorenzo Di Cesare Mannelli、Carla Ghelardini、Claudia Martini、Silvia Selleri
DOI:10.1016/j.bmc.2017.02.013
日期:2017.3
The synthesis of a new series of 6-phenyl- and 6-benzylpyrazolo[1,5-a]pyrimidin-7(4H)-ones 2a-g and 3a-g, strictly related to derivatives with pyrazolobenzotriazine (PBT) and pyrazoloquinazoline (PQ) scaffold, was realized. The in vitro GABAA-receptor subtype affinity was evaluated and from preliminary pharmacological studies, compound 3g shows anxiolytic-like effect at 10-30mg/kg.
Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5-a]pyrimidines: A New Class of KDR Kinase Inhibitors
作者:Mark E. Fraley、William F. Hoffman、Robert S. Rubino、Randall W. Hungate、Andrew J. Tebben、Ruth Z. Rutledge、Rosemary C. McFall、William R. Huckle、Richard L. Kendall、Kathleen E. Coll、Kenneth A. Thomas
DOI:10.1016/s0960-894x(02)00525-5
日期:2002.10
synthesized and evaluated the activity of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines as a newclass of KDR kinase inhibitors. Starting with screening lead 1, potency against isolated KDR was fully optimized with 3-thienyl and 4-methoxyphenyl substituents at the 6- and 3-positions (3g, KDR IC(50)=19 nM), respectively. The synthesis and SAR of these compounds are described.
7-Aminopyrazolo[1,5-<i>a</i>]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors
作者:Robin R. Frey、Michael L. Curtin、Daniel H. Albert、Keith B. Glaser、Lori J. Pease、Niru B. Soni、Jennifer J. Bouska、David Reuter、Kent D. Stewart、Patrick Marcotte、Gail Bukofzer、Junling Li、Steven K. Davidsen、Michael R. Michaelides
DOI:10.1021/jm701397k
日期:2008.7
7-Aminopyrazolo[1,5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered. Investigation of structure-activity relationships of the pyrazolo[1,5-a]pyrimidine nucleus led to a series of 6-(4-N,N'-diphenyl)ureas that potently inhibited a panel of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases. Several of these compounds, such as 34a, are potent inhibitors of kinase insert domain-containing receptor tyrosine kinase (KDR) both enzymatically (< 10 nM) and cellularly (< 10 nM). In addition, compound 34a possesses a favorable pharmacokinetic profile and demonstrates efficacy in the estradiol-induced murine uterine edema (UE) model (ED(50) = 1.4 mg/kg).
Bruni, Fabrizio; Selleri, Silvia; Costanzo, Annarella, Journal of Heterocyclic Chemistry, 1995, vol. 32, # 1, p. 291 - 298
作者:Bruni, Fabrizio、Selleri, Silvia、Costanzo, Annarella、Guerrini, Gabriella、Casilli, Maria Lucia、Giusti, Laura